| Expression pattern: |
UP |
| Associated gene: |
PI3K/Akt/mTOR signaling |
| Associated microRNA: |
miR-613, miR-206 |
| Biological function: |
facilitates chemo-tolerance/chemo-resistance and promotes proliferation, migration and invasion; modulates autophagy; reduces chemosensitivity in TNBC cells |
| Molecular mechanism: |
ceRNA sponging of miR-613 and miR-206 leading to activation of PI3K/Akt/mTOR signaling |
| Biological pathway or process: |
PI3K/AKT/mTOR (promotes); proliferation (promotes); migration (promotes); invasion (promotes); autophagy (other); ceRNA regulation (promotes); chemoresistance (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Survival Analysis; Luciferase Reporter Assay; Transfection; MTT; CCK8; Transwell Assay; Western Blot; In Vivo Animal Model; Bioinformatics Analysis |
| Clinical significance: |
high hsa_circ_0000199 expression was predictive of large tumor size, advanced TNM grade, high Ki-67 level and poor 3-year survival of TNBC patients |
| Description: |
hsa_circ_0000199 (AKT3-derived) is up-regulated in TNBC and promotes malignant phenotypes and chemoresistance. It sponges miR-206 and miR-613 to modulate PI3K/AKT/mTOR signaling, affecting proliferation, migration/invasion, chemosensitivity and autophagy, and its high expression predicts poor survival in TNBC patients. |
| Confidence score: |
0.7126 |